Vagapova, E. R., Lebedev, T. D., & Prassolov, V. S. (2021). Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Nature Portfolio.
Cita Chicago Style (17a ed.)Vagapova, Elmira R., Timofey D. Lebedev, y Vladimir S. Prassolov. Viral Fibrotic Scoring and Drug Screen Based on MAPK Activity Uncovers EGFR as a Key Regulator of COVID-19 Fibrosis. Nature Portfolio, 2021.
Cita MLA (8a ed.)Vagapova, Elmira R., et al. Viral Fibrotic Scoring and Drug Screen Based on MAPK Activity Uncovers EGFR as a Key Regulator of COVID-19 Fibrosis. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.